Vectura Group Share Price (VEC)

128.00 -0.25 (-0.19%) delayed: 9:11PM GMT
Bid price 128.00 Open price 132.00
Ask price 129.25 Prev close 128.00
High price 132.00 Spread 0.97%
Low price 127.00 Volume 252,271

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index n/a

Vectura Group Key Numbers

Latest Share Price (p) 128.00 Net Gearing (%) -0.13
Market Capitalisation (£m) 514.67 Gross Gearing (%) 26.40
Shares in issue (m) 402.46 Debt Ratio 22.10
P/E Ratio -182.69 Debt-to-Equity Ratio 0.79
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.36
Dividend Yield (%) 0.00 Price to book value 2.27
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) -0.70 EPS Growth (%) 61.11
52 week high / low 171.50 / 113.75 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
08/07/2014 BUY Dr Christopher Blackwell CEO 1,212
08/07/2014 BUY Dr Trevor Phillips ED 1,212
08/07/2014 BUY Paul Oliver RES 1,212
02/07/2014 EXR John Brown NED 238,989
02/07/2014 SEXR John Brown NED 159,100

More Vectura Group Director Deals >>

Vectura Group Company News

07:00 19/12/2014

Director Declaration

/* */ RNS Number : 2384A Vectura Group plc 19 December 2014    Vectura Group plc   Director declaration     Chippenham, UK - 19 December 2014 :   In accordance with Listing Rule 9.6.14 (2) Vectura Group plc (LSE:VEC)...

14:57 12/12/2014

Holding(s) in Company

/* */ RNS Number : 6816Z Vectura Group plc 12 December 2014      For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST...

07:46 11/12/2014

Vectura says positive study results for VR475 in asthma

Vectura Group has published the results of a clinical study demonstrating positive results from its Phase IIb/III (Acti-AICS-001) clinical trial investigating the efficacy, safety and tolerability of VR475 in the treatment of oral corticosteroid (OCS)-dependent (GINA Step 5) asthma patients....

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

24 days ago


Powered by IST's

Register now for FREE Vectura Group share price discussions